Skip to main content
Premium Trial:

Request an Annual Quote

BioServe to Process Samples for Fairbanks Institute Heart Study

NEW YORK (GenomeWeb News) – The Fairbanks Institute for Healthy Communities has tapped BioServe to process biological samples for a longitudinal study of coronary artery disease, the company said today.
The Indianapolis, Ind.-based institute will use BioServe’s sample processing services on samples for the Indiana Health Study, which plans to enlist thousands of participants from the Indianapolis region to create a research platform that will support the development of new drugs and diagnostics for chronic diseases including heart disease, cancer, and diabetes.
The study also will use the informatics capabilities of the Regenstrief Institute at Indiana University to study retrospective and prospective medical information.
BioServe said that the Indiana Health Study will integrate biological samples — such as serum, DNA, plasma, and RNA — along with medical data and lifestyle information from patients with coronary artery disease and people without the disease.
Financial terms of the agreement were not released.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.